NF1 and ischemic stroke: Yu et al. studied MLN4924 in the acute phase after ischemic stroke in an in vivo mouse model and found that MLN4924 reduced infarct size and improved functional outcomes via a mechanism involving neurofibromatosis 1 (NF1) and neutrophil reduction [51].